Skip to main content
. 2013 Oct 4;1(1):e00004. doi: 10.1002/prp2.4

Figure 1.

Figure 1

(A, B) Schematic representation of the PTH1R and its biotechnological ligands (tethered or GFP conjugated) discussed or exploited in the present text. (C) Schematic representation of the BK B2R and its GFP-conjugated ligand based on maximakinin (MK).